Latest Alivus Life Sciences stock price
Alivus Life Sciences P/E Ratio
ALIVUS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
21.2
Moderate Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
21.2
Current Price
₹925.45
EPS (TTM)
₹39.63
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.62
Sector Median
25.89
Sector Rank
#11 of 139
Sector Percentile
7.9%
Key P/E Ratio Insights for Alivus Life Sciences
- Trading at discount to sector average PE of 49.62
View the ALIVUS equity price for detailed stock performance.
Related Pages for Alivus Life Sciences
Additional stock information and data for ALIVUS
Sector P/E Ratio Comparison
Comparing Alivus Life Sciences with other companies in Healthcare sector
Sector Average
49.62
Sector Median
25.89
Lowest P/E
0.93
Highest P/E
993.26
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.93 | ₹32 | Low |
| Murae Organisor | MURAE | 2.71 | ₹39 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.51 | ₹1,188 | Low |
| Medicamen Organics | MEDIORG | 6.33 | ₹26 | Low |
| Amwill Health Care | AMWILL | 6.53 | ₹70 | Low |
| Galaxy Medicare | GML | 7.25 | ₹24 | Low |
| Zenith Drugs | ZENITHDRUG | 7.9 | ₹76 | Low |
| Brooks Laboratories | BROOKS | 7.94 | ₹168 | Low |
| Unichem Laboratories | UNICHEMLAB | 8.04 | ₹2,271 | Low |
| Vasundhara Rasayans | VRL | 9.97 | ₹37 | Low |